Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

Routes of Drug Administration: Parenteral

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...

Vaccinations

Vaccinations

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.

Allergy and asthma proceedings·2023

Same author

Allergy immunotherapy for allergic fungal respiratory diseases.

Allergy and asthma proceedings·2023

Same author

The Art of Immunotherapy.

The journal of allergy and clinical immunology. In practice·2023

Same author

The Art of Dosing for Subcutaneous Immunotherapy in North America.

The journal of allergy and clinical immunology. In practice·2023

Same author

Allergy immunotherapy: Literature Review 2022.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023

Same author

Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.

The journal of allergy and clinical immunology. In practice·2022

Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026

Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026

Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026

Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026

Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026

Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Subcutaneous injection immunotherapy for optimal effectiveness.

Harold S Nelson¹

¹Department of Medicine, National Jewish Health and University of Colorado School of Medicine, 1400 Jackson Street, Denver, CO 80206, USA. nelsonh@njhealth.org

Immunology and Allergy Clinics of North America

|May 3, 2011

Summary

This summary is machine-generated.

Subcutaneous immunotherapy using allergen extracts is a 100-year-old treatment proven effective for allergic rhinitis and asthma. This immunotherapy demonstrates dose-dependent efficacy and long-lasting disease-modifying effects.

More Related Videos

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Related Experiment Videos

Last Updated: Jun 2, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Area of Science:

Allergy and Immunology
Immunotherapy Research
Clinical Trials in Allergy

Background:

Subcutaneous immunotherapy (SCIT) with inhalant allergens has been used for a century.
SCIT is established for allergic rhinitis, asthma, and insect sting sensitivity.
Preliminary data suggest SCIT may benefit atopic dermatitis.

Purpose of the Study:

To review the established efficacy and disease-modifying actions of SCIT.
To highlight the dose-dependent nature of SCIT response.
To discuss the long-term benefits of SCIT.

Main Methods:

Review of controlled clinical trials on SCIT efficacy.
Analysis of dose-response relationships in SCIT.
Evaluation of long-term treatment effects and disease modification.

Main Results:

SCIT is effective in treating allergic rhinitis, asthma, and insect sting sensitivity.
SCIT response is directly related to the administered dose.
SCIT can prevent new allergies, asthma development, and effects persist for 7-10 years.

Conclusions:

SCIT is a well-established and effective treatment for allergic diseases.
The dose-dependent nature of SCIT is crucial for optimal outcomes.
SCIT offers significant long-term disease modification and persistent benefits.